Phase I/II study of rhC1INH in the patients with pre-eclampsia
Phase of Trial: Phase I/II
Latest Information Update: 25 Oct 2018
At a glance
- Drugs Conestat alfa (Primary)
- Indications Preeclampsia
- Focus Adverse reactions; Therapeutic Use
- 25 Oct 2018 According to a Pharming Group NV media release, the company expects to get approval for this study and commence this study in the remainder of 2018.
- 17 Oct 2018 According to a Pharming Group NV media release, the company has filed for regulatory approval in the Netherlands and Australia to initiate this clinical trial.
- 01 Aug 2018 New trial record